218 related articles for article (PubMed ID: 20508164)
1. Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.
Friedbichler K; Kerenyi MA; Kovacic B; Li G; Hoelbl A; Yahiaoui S; Sexl V; Müllner EW; Fajmann S; Cerny-Reiterer S; Valent P; Beug H; Gouilleux F; Bunting KD; Moriggl R
Blood; 2010 Sep; 116(9):1548-58. PubMed ID: 20508164
[TBL] [Abstract][Full Text] [Related]
2. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation.
Hoelbl A; Kovacic B; Kerenyi MA; Simma O; Warsch W; Cui Y; Beug H; Hennighausen L; Moriggl R; Sexl V
Blood; 2006 Jun; 107(12):4898-906. PubMed ID: 16493008
[TBL] [Abstract][Full Text] [Related]
3. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
[TBL] [Abstract][Full Text] [Related]
4. The protein tyrosine phosphatase, Shp2, positively contributes to FLT3-ITD-induced hematopoietic progenitor hyperproliferation and malignant disease in vivo.
Nabinger SC; Li XJ; Ramdas B; He Y; Zhang X; Zeng L; Richine B; Bowling JD; Fukuda S; Goenka S; Liu Z; Feng GS; Yu M; Sandusky GE; Boswell HS; Zhang ZY; Kapur R; Chan RJ
Leukemia; 2013 Feb; 27(2):398-408. PubMed ID: 23103841
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.
Freund P; Kerenyi MA; Hager M; Wagner T; Wingelhofer B; Pham HTT; Elabd M; Han X; Valent P; Gouilleux F; Sexl V; Krämer OH; Groner B; Moriggl R
Leukemia; 2017 Oct; 31(10):2132-2142. PubMed ID: 28074064
[TBL] [Abstract][Full Text] [Related]
6. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem/progenitor cells.
Casetti L; Martin-Lannerée S; Najjar I; Plo I; Augé S; Roy L; Chomel JC; Lauret E; Turhan AG; Dusanter-Fourt I
Cancer Res; 2013 Apr; 73(7):2052-8. PubMed ID: 23400594
[TBL] [Abstract][Full Text] [Related]
7. Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.
Woock AE; Grible JM; Olex AL; Harrell JC; Zot P; Idowu M; Clevenger CV
Sci Rep; 2021 Jun; 11(1):13506. PubMed ID: 34188118
[TBL] [Abstract][Full Text] [Related]
8. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
9. PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis.
Berger A; Hoelbl-Kovacic A; Bourgeais J; Hoefling L; Warsch W; Grundschober E; Uras IZ; Menzl I; Putz EM; Hoermann G; Schuster C; Fajmann S; Leitner E; Kubicek S; Moriggl R; Gouilleux F; Sexl V
Leukemia; 2014 Mar; 28(3):629-41. PubMed ID: 24263804
[TBL] [Abstract][Full Text] [Related]
10. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
11. STAT5 signaling is required for the efficient induction and maintenance of CML in mice.
Ye D; Wolff N; Li L; Zhang S; Ilaria RL
Blood; 2006 Jun; 107(12):4917-25. PubMed ID: 16522816
[TBL] [Abstract][Full Text] [Related]
12. STAT5A Modulates Chemokine Receptor CCR6 Expression and Enhances Pre-B Cell Growth in a CCL20-Dependent Manner.
Tsuruyama T; Hiratsuka T; Aini W; Nakamura T
J Cell Biochem; 2016 Nov; 117(11):2630-42. PubMed ID: 27018255
[TBL] [Abstract][Full Text] [Related]
13. BCR-ABL affects STAT5A and STAT5B differentially.
Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
[TBL] [Abstract][Full Text] [Related]
14. Stat5 tetramer formation is associated with leukemogenesis.
Moriggl R; Sexl V; Kenner L; Duntsch C; Stangl K; Gingras S; Hoffmeyer A; Bauer A; Piekorz R; Wang D; Bunting KD; Wagner EF; Sonneck K; Valent P; Ihle JN; Beug H
Cancer Cell; 2005 Jan; 7(1):87-99. PubMed ID: 15652752
[TBL] [Abstract][Full Text] [Related]
15. STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells.
Schepers H; van Gosliga D; Wierenga AT; Eggen BJ; Schuringa JJ; Vellenga E
Blood; 2007 Oct; 110(8):2880-8. PubMed ID: 17630355
[TBL] [Abstract][Full Text] [Related]
16. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
18. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
19. Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis.
Joliot V; Cormier F; Medyouf H; Alcalde H; Ghysdael J
Oncogene; 2006 Aug; 25(33):4573-84. PubMed ID: 16532027
[TBL] [Abstract][Full Text] [Related]
20. Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2(V617F) in mice.
Walz C; Ahmed W; Lazarides K; Betancur M; Patel N; Hennighausen L; Zaleskas VM; Van Etten RA
Blood; 2012 Apr; 119(15):3550-60. PubMed ID: 22234689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
